NPR | Where Does Alzheimer's Treatment Go From Here? NPR The company has pressed on with tests of solanezumab, despite mixed results in earlier studies. The latest test, involving more than 2,000 patients, found the drug didn't significantly slow cognitive decline in patients with mild dementia from Alzheimer's. Quick 'sniff test' detects early signs of Alzheimer's Strong Heart, Better Education Shown to Lower Dementia Risk |